PillRx only · Injection, Solution · Intravenous
Dopamine Hydrochloride
Dopamine Hydrochloride
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
122
Rx · 2026 Q1
31K
Units dispensed
-45%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Baxter Healthcare Corporation | unknown | 5 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 2 | SUPPLYING |
| ProPharma Distribution | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Nov 6, 2017SHORTAGEDrug shortage: Dopamine Hydrochloride Injection (Baxter Healthcare)
Dopamine Hydrochloride Injection — reported in shortage by Baxter Healthcare. Therapeutic category: Cardiovascular.
- Sep 29, 2014RECALLRecall (Class II): DOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only, Baxter USA, NDC 0338-1005-02.
Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the overpouch. — Recalling firm: Baxter Healthcare Corp. — Nationwide and Canada